It is a pharma foreign private limited company based in Kanchipuram, Tamil Nadu, India, established in 2021.
2021 | Kanchipuram, Tamil Nadu, India | ActiveOrbion Pharmaceuticals Private Limited, a active foreign private limited company, was established on 31 May 2021 in Kanchipuram, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100TN2021FTC143806. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹175.00 Cr and a paid-up capital of ₹175.00 Cr.
Employing 250 professional, Its leadership includes Mridul Dhanuka (Director), Bajrang Dass Garg (Director), Phanindranath Ramachandran Punji (Director). Past directors included Ashok Kumar Hegde. It holds ₹75.00 Cr open charges and no settled loans. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot B5 (Part) & Plot B6 (Part), Sipcot Industrial Park, Irrungatukottai, Sriperumbudur Tal, Uk,, Kanchipuram, Tamil Nadu, 602117.
U24100TN2021FTC143806
143806
31 May 2021
₹175.00 Cr
₹175.00 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Orbion Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mridul Dhanuka | Director | 31 May 2021 | Current |
| Bajrang Dass Garg | Director | 17 Aug 2021 | Current |
| Phanindranath Ramachandran Punji | Director | 17 Aug 2021 | Current |
| Ashok Kumar Hegde | Managing Director | 31 May 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Aug 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Orbion Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Orbion Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹750,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jul 2023 | Hdfc Bank Limited | ₹75.00 Cr | Open |
Explore comprehensive loan charge details -
Orbion Pharmaceuticals has a workforce of 250 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Orbion Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orbion Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Hdfc Bank Limited of Rs. 75.00 Cr registered on 17 Jul 2023 with Charge ID 100750600 was modified on 25 Sep 2025. was recorded as a recent event.
The activity Orbion Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records. was completed.
Progress on Orbion Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 75.00 Cr with Charge ID 100750600 was registered on 17 Jul 2023. was recorded as a recent event.
The activity Sakthivel Ganapathy was appointed as a Company Secretary was appointed as a Company Secretary on 06 Oct 2022 & has been associated with this company since 3 years 1 month . was completed.
The activity Bajrang Dass Garg was appointed as a Director was appointed as a Director on 17 Aug 2021 & has been associated with this company since 4 years 3 months . was completed.
The CIN of Orbion Pharmaceuticals Private Limited is U24100TN2021FTC143806.
Orbion Pharmaceuticals Private Limited is headquartered at Plot B5 (Part) & Plot B6 (Part), Sipcot Industrial Park, Irrungatukottai, Sriperumbudur Tal, Uk,, Kanchipuram, Tamil Nadu, 602117.
Orbion Pharmaceuticals Private Limited was incorporated on 31 May 2021.
The current directors of Orbion Pharmaceuticals Private Limited are
The primary industry of Orbion Pharmaceuticals Private Limited is Manufacturing.
Orbion Pharmaceuticals Private Limited is unlisted.
The authorized capital of Orbion Pharmaceuticals Private Limited is ₹175.00 Cr, and the paid-up capital is ₹175.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX